4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-24-052606
Chairman and CEO bought 769 shares at an average $1.71 ($1,318)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KAZIMI A J Chairman and CEO | 2024-12-02 | Purchase 10b5-1 | +70 | $1.33 | $93 | 5,701,597 | D |
| KAZIMI A J Chairman and CEO | 2024-12-03 | Purchase 10b5-1 | +70 | $1.26 | $88 | 5,701,667 | D |
| KAZIMI A J Chairman and CEO | 2024-12-04 | Purchase 10b5-1 | +70 | $1.22 | $85 | 5,701,737 | D |
| KAZIMI A J Chairman and CEO | 2024-12-05 | Purchase 10b5-1 | +65 | $1.20 | $78 | 5,701,802 | D |
| KAZIMI A J Chairman and CEO | 2024-12-06 | Purchase 10b5-1 | +70 | $1.20 | $84 | 5,701,872 | D |
| KAZIMI A J Chairman and CEO | 2024-12-09 | Purchase 10b5-1 | +70 | $1.25 | $88 | 5,701,942 | D |
| KAZIMI A J Chairman and CEO | 2024-12-10 | Purchase 10b5-1 | +32 | $2.48 | $79 | 5,701,974 | D |
| KAZIMI A J Chairman and CEO | 2024-12-11 | Purchase 10b5-1 | +32 | $2.29 | $73 | 5,702,006 | D |
| KAZIMI A J Chairman and CEO | 2024-12-12 | Purchase 10b5-1 | +32 | $2.19 | $70 | 5,702,038 | D |
| KAZIMI A J Chairman and CEO | 2024-12-13 | Purchase 10b5-1 | +32 | $2.33 | $75 | 5,702,070 | D |
| KAZIMI A J Chairman and CEO | 2024-12-16 | Purchase 10b5-1 | +49 | $2.21 | $108 | 5,702,119 | D |
| KAZIMI A J Chairman and CEO | 2024-12-17 | Purchase 10b5-1 | +49 | $2.12 | $104 | 5,702,168 | D |
| KAZIMI A J Chairman and CEO | 2024-12-18 | Purchase 10b5-1 | +49 | $2.19 | $107 | 5,702,217 | D |
| KAZIMI A J Chairman and CEO | 2024-12-19 | Purchase 10b5-1 | +40 | $2.33 | $93 | 5,702,257 | D |
| KAZIMI A J Chairman and CEO | 2024-12-20 | Purchase 10b5-1 | +39 | $2.35 | $92 | 5,702,296 | D |
| Open-market purchases · 769 sh · avg $1.71 · $1,318 | |||||||
Loading xslF345X05/wk-form4_1735605852.xml…